|
Davis Polk & Wardwell and Global Law Office are advising Chinese bubble-tea maker Nayuki Holdings on its planned IPO in Hong Kong, with Kirkland & Ellis and Jingtian & Gongcheng advising the joint sponsors.
|
Davis Polk & Wardwell and Global Law Office are advising medical research firm CARsgen Therapeutics on its planned IPO in Hong Kong, with Herbert Smith Freehills and Zhong Lun Law Firm advising the joint underwriters. The IPO is expected to raise up to $400 million.
|
Skadden, Arps, Slate, Meagher & Flom and Global Law Office Shanghai have advised Chinese courier ZTO Express on its $1.55 billion secondary listing on the Hong Kong Stock Exchange, with Freshfields Bruckhaus Deringer and JunHe counselling the sponsor and the underwriters.
|
On January 1, 2020, the new Foreign Investment Law (FIL) of the People’s Republic of China and its Implementing Regulations came into force, formally replacing the so-called Three Foreign Investment Laws which has a history of nearly 40 years in China, marking the arrival of a new era of foreign investment.